Constitutive expression of interferon beta in differentiated epithelial cells exposed to environmental stimuli

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 5, 1998, Pages 375-382

  Bielenberg, Diane R ^a   Fidler, Isaiah J ^a,b   Bucana, Corazon D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Differentiation; Epithelial cells; Host defense; Interferon

Indexed keywords

BETA INTERFERON;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; EPITHELIUM CELL; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULUS RESPONSE;

EID: 0032408111     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.375     Document Type: Article

References (18)

1. rd ed. Churchill, New York, 1993.
2. Davies JA, Garrod DR. Molecular aspects of the epithelial phenotype. Bioessays 1997;19:699-704.
3. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Ser B 1957;147:258-267.
4. Gresser I. Biologic effects of interferons. J Invest Dermatol 1990; 95:66S-71S.
5. De Maeyer-Guignard J, De Maeyer E. Immunomodulation by interferons: recent developments. Interferon 1985;6:69-91.
6. Tamm I, Lin SL, Pfeffer LM, Sehgal PB. Interferons α and β as cellular regulatory molecules. Interferon 1987;9:13-74.
7. Kalvakolanu DV, Borden EC. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest 1996;14:25-53.
8. Dianzani F. Interferon treatments: how to use an endogenous system as a therapeutic agent. J Interferon Res 1992;(Spec issue):109-118.
9. Real FX, Oettgen HF, Krown SE. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 1986;4:544-551.
10. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy [published errata appear in N Engl J Med 1994 330:300 and 1995 333:595-6]. N Engl J Med 1992;326:1456-1463.
11. Migliari R, el Demiry M, Muscas G, Usai E. Intravesical instillation of beta-interferon in the treatment of bladder cancer. Br J Urol 1992;70:169-173.
12. Borden EC. Interferons - expanding therapeutic roles. N Engl J Med 1992;326:1491-1493.
13. Tucker SB. Interferon-alpha treatment of basal cell and squamous cell skin tumors. Cancer Bull 1992; 45:270-274.
14. Lengyel P. Biochemistry of interferons and their actions. Annu Rev Biochem 1982;51:251-282.
15. Clemens MJ, McNurlan MA. Regulation of cell proliferation and differentiation by interferons. Biochem J 1985;226:345-360.
16. Heyns AP, Eldor A, Vlodavsky I, Kaiser N, Fridman R, Panet A. The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Exp Cell Res 1985; 161:297-306.
17. Rossi GB. Interferons and cell differentiation. In Interferon 6. Academic Press, London, 1985; 31-68.
18. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987;47:5155-5161.